Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,615 | 13,311 | 10,061 | 11,500 | 3,913 |
| TOTAL | $11,386 | $13,952 | $10,474 | $12,193 | $4,181 |
| Non-Current Assets | |||||
| PPE Net | 435 | 543 | 245 | 1,444 | 1,729 |
| Intangibles | 0 | 0 | 1,676 | 1,676 | 1,676 |
| Other Non-Current Assets | 430 | 559 | 478 | 12 | 12 |
| TOTAL | $865 | $1,102 | $2,398 | $3,131 | $3,416 |
| Total Assets | $12,251 | $15,054 | $12,872 | $15,325 | $7,596 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,664 | 1,544 | 1,868 | 1,416 | 676 |
| Other current liabilities | N/A | 43 | 105 | 127 | 4,781 |
| TOTAL | $2,770 | $1,622 | $2,115 | $1,633 | $5,703 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 33 | 139 | N/A | N/A |
| Other Non-Current Liabilities | 422 | 171 | 0 | 147 | 236 |
| TOTAL | $422 | $171 | $2 | $152 | $244 |
| Total Liabilities | $3,191 | $1,793 | $2,117 | $1,785 | $5,947 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 31 | 16 | 6 | 4 | 0 |
| Retained earnings | -111,681 | -97,588 | -84,349 | -70,787 | -64,607 |
| TOTAL | $9,059 | $13,261 | $10,755 | $13,540 | $1,650 |
| Total Liabilities And Equity | $12,251 | $15,054 | $12,872 | $15,325 | $7,596 |